Onconova Therapeutics (ONTX) Earnings Date, Estimates & Call Transcripts → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free ONTX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesShort InterestSocial Media Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueONTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ONTX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.” Onconova Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.72) EPSNext Year EPS Consensus Estimate: ($0.86) EPS Onconova Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript11/14/2023Q3 2023($0.26)($0.23)+$0.03($0.23)$0.06 million$0.06 million8/10/2023Q2 2023($0.29)($0.20)+$0.09($0.20)$0.06 million$0.06 million 5/15/2023Q1 2023($0.27)($0.28)($0.01)($0.28)$0.06 million$0.06 million3/16/2023Q4 2022($0.27)($0.26)+$0.01($0.26)$0.08 million$0.06 million11/14/2022Q3 2022($0.21)($0.26)($0.05)($0.26)$0.06 million$0.06 million8/11/2022Q2 2022($0.20)($0.19)+$0.01($0.19)$0.06 million$0.06 million Get the Latest News and Ratings for ONTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Onconova Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/11/2022Q1 2022($0.18)($0.20)($0.02)($0.20)$0.06 million$0.06 million 3/17/2022Q4 2021-($0.16)($0.16)($0.16)$0.08 million$0.06 million 11/11/2021Q3 2021($0.33)($0.22)+$0.11($0.22)$0.06 million$0.06 million 8/12/2021Q2 2021($0.28)($0.27)+$0.01($0.27)$0.04 million$0.06 million 5/17/2021Q1 2021($0.45)($0.30)+$0.15($0.02)$0.06 million$0.06 million 3/11/2021Q4 2020($0.60)($0.45)+$0.15($0.03)$0.05 million$0.06 million 11/12/2020Q3 2020($0.30)($0.45)($0.15)($0.03)$4.10 million$0.07 million 8/12/2020Q2 2020($0.45)($0.60)($0.15)($0.04)$0.40 million$0.06 million 5/14/2020Q1 2020($0.60)($0.45)+$0.15($0.03)$0.10 million$0.05 million 11/12/2019Q3 2019($11.40)($11.25)+$0.15($0.75)$0.31 million$0.06 million8/14/2019Q2 2019($14.70)($9.00)+$5.70($0.60)$0.25 million$2.02 million Onconova Therapeutics Earnings - Frequently Asked Questions How much revenue does Onconova Therapeutics generate each year? Onconova Therapeutics (NASDAQ:ONTX) has a recorded annual revenue of $230,000.00. How much profit does Onconova Therapeutics generate each year? Onconova Therapeutics (NASDAQ:ONTX) has a recorded net income of -$18.96 million. ONTX has generated -$0.91 earnings per share over the last four quarters. What is Onconova Therapeutics's EPS forecast for next year? Onconova Therapeutics's earnings are expected to decrease from ($0.72) per share to ($0.86) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Orgenesis Earnings Date MEI Pharma Earnings Date Lumos Pharma Earnings Date Alaunos Therapeutics Earnings Date Synlogic Earnings Date Benitec Biopharma Earnings Date BioVie Earnings Date NeuroBo Pharmaceuticals Earnings Date KALA BIO Earnings Date Cumberland Pharmaceuticals Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: PDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets Uncertainty This page (NASDAQ:ONTX) was last updated on 5/23/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyWrite this ticker symbol down…StocksToTradeTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaElon to Transform U.S. Economy? Porter & CompanyThe Presidential candidate you should REALLY be worried aboutStansberry ResearchThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Onconova Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.